UCB's Cimzia has received Food & Drug Administration approval for treating Crohn's disease.
Crohn’s disease patients have a new monthly treatment option open to them. It’s UCB’s UCB claims Cimzia is the first and only PEGylated anti-tumor necrosis factor alpha antibody indicated for this
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.